Table 1 Baseline patient characteristics.

From: High-density Mapping Guided Pulmonary Vein Isolation for Treatment of Atrial Fibrillation - Two-year clinical outcome of a single center experience

 

Overall

(n = 108)

HDM group (n = 54)

COM group (n = 54)

p-value

Paroxysmal AF, n (%)

55 (50.9)

29 (53.7)

26 (48.1)

0.56

Age, years

63.9 ± 11.2

65.0 ± 12.0

62.9 ± 10.3

0.32

Male sex, n (%)

61 (56.5)

28 (51.9)

33 (61.1)

0.44

CHA2DS2-VASc

2.5 ± 1.6

2.6 ± 1.8

2.3 ± 1.5

0.41

LVEF, %

61.5 ± 10.9

59.9 ± 9.7

62.9 ± 11.7

0.17

LA diameter, mm

40.9 ± 7.1

40.3 ± 7.7

41.3 ± 6.7

0.51

Smoking, n (%)

21 (19.4)

11 (20.4)

10 (18.6)

0.96

Diabetes mellitus, n (%)

15 (13.9)

8 (14.8)

7 (13.0)

0.91

Stroke, n (%)

13 (12.0)

7 (13.0)

6 (11.1)

0.85

Hypertension, n (%)

77 (71.3)

38 (70.4)

43 (79.6)

0.38

Coronary artery disease, n (%)

22 (20.4)

13 (24.1)

9 (16.7)

0.42

Betablocker, n (%)

95 (88.0)

46 (85.2)

49 (90.7)

0.52

Class I AAD, n (%)

19 (17.6)

10 (18.5)

9 (16.7)

0.80

Class III AAD, n (%)

16 (14.8)

10 (18.5)

6 (11.1)

0.28

  1. HDM, high density mapping; COM, conventional mapping; AF, atrial fibrillation; LVEF, left ventricular ejection fraction; LA, left atrial; AAD, anti-arrhythmic drugs.
Back to article page